India MCA Insolvency Liquidation Filings — June 05, 2026

NCLT sanction of Dhanuka Laboratories amalgamation creates a combined entity with potential synergies; no financials disclosed, but the scheme being on a going-concern basis implies asset value preservation.

NCLT approval of PureSoftware merger with appointed date April 1, 2026, streamlines corporate structure and could unlock cost synergies; the merger of a wholly owned subsidiary is a low-risk restructuring.

Continued CIRP delays (adjourned to July 8, 2026) signal no near-term resolution; the company has been under CIRP since February 2022 (over 4 years), indicating deep structural issues.

Fresh Section 9 petition for ₹5.17 Cr by operational creditor UCN Cable Network is a material event that could trigger insolvency proceedings, severely impacting operations and financial position.

The amalgamation is under SEBI LODR Regulation 30, suggesting a material event; the NCLT order receipt on June 5, 2026, is a positive catalyst for the stock.

The certified copy of the NCLT order received on June 5, 2026, removes regulatory overhang; the appointed date of April 1, 2026, allows for retroactive accounting consolidation.

The resolution plan approval application (IA 1538/2022) was not even heard due to time constraints, indicating court backlog and procedural inefficiency; this is a negative signal for recovery prospects.

The petition was filed under Section 9 (operational creditor), which typically has a faster track than financial creditor petitions; the company's management (Chairman Ravi Gautam Adhikari) flagged it as material, suggesting limited defenses.

The company has been under CIRP since February 2, 2022 (over 4 years), and the resolution plan approval was not heard on June 2, 2026, with adjournment to July 8, 2026. This is an extreme delay, increasing the risk of liquidation.

A Section 9 petition for ₹5.17 Cr by UCN Cable Network could lead to NCLT admission, triggering a moratorium and management displacement. The company warns it may impact operations and financial position.

The court did not take up the resolution plan approval due to time constraints, suggesting systemic backlog. This increases uncertainty for creditors and equity holders.

Operational creditor petitions often signal supplier distress; if admitted, other operational creditors may file similar petitions, creating a cascade.

While the NCLT sanction is positive, the amalgamation of Dhanuka Laboratories involves integration risks (culture, systems, liabilities) that are not disclosed.

The filing lacks any financial details of PureSoftware (revenue, profitability, debt), making it impossible to assess the merger's value impact.

None of the four filings contain insider trading data (no purchases, sales, or pledges). This lack of management conviction signals is a concern, especially for distressed entities.

The Chairman & MD personally signed the filing warning of material impact, indicating the company may lack liquidity to settle the ₹5.17 Cr claim.

The NCLT-sanctioned amalgamation of Dhanuka Laboratories could create cost and revenue synergies; investors should watch for the scheme document for financial details.

The merger of PureSoftware (wholly owned subsidiary) eliminates a layer of corporate structure, potentially improving governance and reducing compliance costs.

If the resolution plan is approved on July 8, 2026, it could provide a recovery for creditors and potentially equity holders; the current delay creates a buying opportunity for distressed debt investors.

The company may negotiate a settlement with UCN Cable Network before NCLT admission, avoiding insolvency; such settlements often occur at a discount to the claimed amount.

The NCLT sanction is a key regulatory milestone; the stock may re-rate as the amalgamation progresses, especially if the combined entity has improved financials.

The appointed date of April 1, 2026, allows the merger to be accounted for retroactively, potentially boosting FY26 financials with PureSoftware's results.

The July 8, 2026, hearing is a binary event; if the resolution plan is approved, the stock could see a sharp upward move.

If the company survives the Section 9 petition, its assets may be undervalued; the petition amount of ₹5.17 Cr is small relative to potential asset value.

2/4 filings (Orchid Pharma, Happiest Minds) show successful NCLT approvals for schemes of arrangement, while 2/4 (Vikas WSP, TV Vision) show distress escalation. This suggests a 'two-speed' insolvency market where well-prepared companies exit quickly, while others languish. [IMPLICATION: Favor companies with clean restructuring exits; avoid those with procedural delays.]

TV Vision's Section 9 petition by UCN Cable Network highlights growing operational creditor activism under IBC. This trend could pressure other companies with weak supplier relationships. [IMPLICATION: Monitor companies with high trade payables and low liquidity.]

Vikas WSP has been under CIRP for over 4 years, far exceeding the 330-day statutory timeline. This underscores the systemic issue of NCLT backlog and prolonged resolution processes. [IMPLICATION: Avoid companies that have been in CIRP for >2 years without resolution plan approval.]

Both Orchid Pharma and Happiest Minds are using schemes of arrangement to simplify corporate structures (amalgamation of subsidiaries/affiliates). This trend is positive for governance and valuation. [IMPLICATION: Look for companies with complex structures that may announce similar schemes.]

None of the four filings disclosed financial metrics (revenue, debt, valuation). This opacity limits investor ability to assess value creation/destruction. [IMPLICATION: Demand more granular data from companies; rely on subsequent scheme documents.]

The next hearing on July 8, 2026, for both the Section 19(2) application and the resolution plan approval is a critical catalyst. Watch for approval or further delays. [Date: July 8, 2026]

Monitor whether the NCLT admits the petition or if the company settles with UCN Cable Network. The company's financial position and liquidity are key. [Date: Ongoing]

Watch for the filing of the NCLT order and the scheme document, which will disclose financial details of Dhanuka Laboratories and the combined entity. [Date: TBD]

Monitor the effective date of the merger and any subsequent filings on the impact of PureSoftware's consolidation. [Date: Post-April 1, 2026]

If the plan is approved on July 8, watch for the resolution plan summary, including haircut for creditors and any equity value for existing shareholders. [Date: July 8, 2026]

Watch for any additional Section 9 petitions from other operational creditors, which could signal a broader liquidity crisis. [Date: Ongoing]

The NCLT sanction is a positive catalyst; monitor the stock's price and volume for re-rating signals. [Date: Immediate]

The merger simplifies the corporate structure; watch for any insider trading activity (buying/selling) post-approval as a signal of management confidence. [Date: Ongoing]